// App-Quantinova.ai

372 : Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations

Researchers

Presenter

  • C. Carroll

Principal Investigators

  • A. Lees

  • J. Ferreira

  • M. Fonseca

  • D. Magalhaes

  • J. Rocha

  • P. Soares-da-Silva

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • entacapone

  • Levodopa

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved